@article{JTD146,
author = {Kurt Ulm},
title = {Primary endpoints in cancer trials},
journal = {Journal of Thoracic Disease},
volume = {3},
number = {2},
year = {2011},
keywords = {},
abstract = {There is an ongoing discussion about the selection of the most appropriate primary endpoint in cancer trials. Most papers are comparing progression-free survival (PFS) with overall survival (OS). Alternatives could be disease-free survival (DFS) or time to treatment failure (TTF). Another option could be the quality of life.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/146}
}